These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 26064418)

  • 21. Mitochondrial therapeutic interventions in Alzheimer's disease.
    Van Giau V; An SSA; Hulme JP
    J Neurol Sci; 2018 Dec; 395():62-70. PubMed ID: 30292965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines.
    Milane L; Dolare S; Jahan T; Amiji M
    Nanomedicine; 2021 Oct; 37():102422. PubMed ID: 34175455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription.
    Tatton WG; Chalmers-Redman RM; Ju WY; Wadia J; Tatton NA
    J Neural Transm Suppl; 1997; 49():245-68. PubMed ID: 9266433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of mitochondrial function in glutamate-dependent metabolism in neuronal cells.
    Smaili SS; Ureshino RP; Rodrigues L; Rocha KK; Carvalho JT; Oseki KT; Bincoletto C; Lopes GS; Hirata H
    Curr Pharm Des; 2011 Dec; 17(35):3865-77. PubMed ID: 21933141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.
    Jin H; Kanthasamy A; Ghosh A; Anantharam V; Kalyanaraman B; Kanthasamy AG
    Biochim Biophys Acta; 2014 Aug; 1842(8):1282-94. PubMed ID: 24060637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases.
    Stanga S; Caretto A; Boido M; Vercelli A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approaches to Mitigate Mitochondrial Dysfunction in Sensorineural Hearing Loss.
    Okur MN; Djalilian HR
    Ann Biomed Eng; 2022 Dec; 50(12):1762-1770. PubMed ID: 36369597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders.
    Almikhlafi MA; Karami MM; Jana A; Alqurashi TM; Majrashi M; Alghamdi BS; Ashraf GM
    Curr Neuropharmacol; 2023; 21(5):1165-1183. PubMed ID: 36043795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease.
    Reddy PH
    CNS Spectr; 2009 Aug; 14(8 Suppl 7):8-13; discussion 16-8. PubMed ID: 19890241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease.
    Fitzgerald JC; Zimprich A; Carvajal Berrio DA; Schindler KM; Maurer B; Schulte C; Bus C; Hauser AK; Kübler M; Lewin R; Bobbili DR; Schwarz LM; Vartholomaiou E; Brockmann K; Wüst R; Madlung J; Nordheim A; Riess O; Martins LM; Glaab E; May P; Schenke-Layland K; Picard D; Sharma M; Gasser T; Krüger R
    Brain; 2017 Sep; 140(9):2444-2459. PubMed ID: 29050400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical effects of chemical exposures on mitochondrial function.
    Zolkipli-Cunningham Z; Falk MJ
    Toxicology; 2017 Nov; 391():90-99. PubMed ID: 28757096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.
    Li Y; Zhao J; Hölscher C
    CNS Drugs; 2017 Aug; 31(8):639-652. PubMed ID: 28634902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondria: prospective targets for neuroprotection in Parkinson's disease.
    Yadav A; Agarwal S; Tiwari SK; Chaturvedi RK
    Curr Pharm Des; 2014; 20(35):5558-73. PubMed ID: 24606805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A focus on natural products for preventing and cure of mitochondrial dysfunction in Parkinson's disease.
    Mohammadipour A
    Metab Brain Dis; 2022 Apr; 37(4):889-900. PubMed ID: 35156154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson's disease.
    Li DW; Yao M; Dong YH; Tang MN; Chen W; Li GR; Sun BQ
    Int J Mol Med; 2014 Nov; 34(5):1358-64. PubMed ID: 25174304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Insight Into Mitochondrial Dysfunction and its Implications in Neurological Diseases.
    Waseem R; Shamsi A; Kazim SN; Islam A
    Curr Drug Targets; 2021; 22(14):1585-1595. PubMed ID: 33390128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.
    Correia SC; Santos RX; Perry G; Zhu X; Moreira PI; Smith MA
    Adv Exp Med Biol; 2012; 724():205-21. PubMed ID: 22411245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondria dysfunction and neurodegenerative disorders: cause or consequence.
    Morais VA; De Strooper B
    J Alzheimers Dis; 2010; 20 Suppl 2():S255-63. PubMed ID: 20463408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.